Novartis Investigative Site
Clackamas, Oregon 97015
0 studies enrolling now · 1 studies all time
What they study most
Chronic Spontaneous Urticaria
Studies at this site
Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab
— Stopped early